pharmaphorum Podcast
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Listen on:
Episodes
Friday Dec 17, 2021
Friday Dec 17, 2021
This episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led clinician, consultant and patient advocate, Mark Duman.
Thursday Nov 25, 2021
Thursday Nov 25, 2021
In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the guests discuss qualitative real-world evidence and a unique dementia project from Singapore.
Friday Nov 12, 2021
Friday Nov 12, 2021
Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes.
Friday Nov 05, 2021
Friday Nov 05, 2021
In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.
Friday Oct 29, 2021
Friday Oct 29, 2021
This episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s being led by Mark Duman, a clinician, consultant and patient advocate.
Friday Oct 15, 2021
Friday Oct 15, 2021
Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.
Monday Oct 04, 2021
Monday Oct 04, 2021
Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.
Wednesday Sep 22, 2021
Wednesday Sep 22, 2021
As the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.
Wednesday Sep 08, 2021
Wednesday Sep 08, 2021
The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology.
Monday Aug 23, 2021
Monday Aug 23, 2021
In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.